Sign In
Buy CLPBY
$5.93
+0.0245 (+0.415%)
At Close: Jun 03, 2026
CLPBY vs. PEN: Which Stock Is the Better Value Option?
12:42pm, Monday, 12'th Jan 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both Coloplast A/S Sponsored ADR (CLPBY) and Penumbra (PEN). But which of these two stocks offers value investors a b
Coloplast announces changes to Executive Leadership Team
09:00am, Thursday, 18'th Dec 2025
Today, Coloplast is announcing changes to the company's Executive Leadership Team (ELT). The changes relate to the company's Interventional Urology business as well as the global People & Culture func
Coloplast A/S (CLPBY) Shareholder/Analyst Call Transcript
04:58pm, Thursday, 04'th Dec 2025
Coloplast A/S (CLPBY) Shareholder/Analyst Call Transcript
Coloplast A/S - Decisions at the Annual General Meeting 2025
11:50am, Thursday, 04'th Dec 2025
Today, 4 December 2025, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2024/25 was approved. Distribution of y
Coloplast A/S (CLPBY) Q4 2025 Earnings Call Transcript
08:46am, Tuesday, 04'th Nov 2025
Coloplast A/S (OTCPK:CLPBY) Q4 2025 Earnings Call November 4, 2025 5:00 AM EST Company Participants Lars Rasmussen Anders Lonning-Skovgaard - Executive VP & CFO Conference Call Participants Hassan Al-
After A 50% Decline, Coloplast Might Finally Be Worth Buying
05:40am, Wednesday, 29'th Oct 2025
Coloplast is now rated a cautious 'Buy,' as its valuation has become more reasonable after a significant price correction. Coloplast continues to deliver solid organic growth, boasts a wide economic m
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
11:52am, Thursday, 09'th Oct 2025
Announcement no. 09/2025Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Coloplast interim CEO Lars Rasmussen has tod
Coloplast A/S - Financial Calendar 2025-26
08:39am, Tuesday, 30'th Sep 2025
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://www.coloplast.com/investor-relations/events-calendar/ Kind regards,Investor Relations
Coloplast A/S (CLPBY) Capital Markets Day 2025 Transcript
03:30pm, Tuesday, 02'nd Sep 2025
Coloplast A/S (OTCPK:CLPBY) Capital Markets Day 2025 September 2, 2025 4:30 AM EDT Company Participants Lars Rasmussen Anders Lonning-Skovgaard - Executive VP & CFO Caroline Rosenstand - Executive Vic
Coloplast A/S (CLPBF) Q3 2025 Earnings Call Transcript
12:33pm, Tuesday, 19'th Aug 2025
Coloplast A/S (OTCPK:CLPBF) Q3 2025 Earnings Conference Call August 19, 2025 5:00 AM ET Company Participants Anders Lonning-Skovgaard - Executive VP & CFO Lars Soren Rasmussen - Interim CEO & Director
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025
09:44am, Tuesday, 19'th Aug 2025
Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For thos
Coloplast: Finally Getting Buyable
11:00am, Saturday, 14'th Jun 2025
Coloplast is a global leader in specialized intimate healthcare, with strong innovation, high margins, and a defensible moat in core segments. Despite a 20% share price drop, I see upside potential, b
Coloplast A/S (CLPBF) Q2 2025 Earnings Call Transcript
04:36am, Saturday, 10'th May 2025
Coloplast A/S (OTCPK:CLPBF) Q2 2025 Earnings Conference Call May 6, 2025 5:00 AM ET Company Participants Lars Søren Rasmussen - Interim CEO Anders Lonning-Skovgaard - Chief Financial Officer Conferen
Coloplast price target lowered to DKK 655 from DKK 694 at Morgan Stanley
01:22pm, Wednesday, 07'th May 2025
Morgan Stanley lowered the firm's price target on Coloplast to DKK 655 from DKK 694 and keeps an Underweight rating on the shares.
Coloplast A/S CEO Kristian Villumsen steps down as of today
11:11am, Monday, 05'th May 2025
Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO.
